Journal
BIOLOGICAL CHEMISTRY
Volume 390, Issue 9, Pages 845-849Publisher
WALTER DE GRUYTER GMBH
DOI: 10.1515/BC.2009.103
Keywords
cell therapy; differentiation; induced pluripotency; in vitro reprogramming; tumour formation
Categories
Ask authors/readers for more resources
Adult cells have been reprogrammed into induced pluripotent stem (iPS) cells by introducing pluripotency-associated transcription factors. Here, we discuss recent advances and challenges of in vitro reprogramming and future prospects of iPS cells for their use in diagnosis and cell therapy. The generation of patient-specific iPS cells for clinical application requires alternative strategies, because genome-integrating viral vectors may cause insertional mutagenesis. Moreover, when suitable iPS cell lines will be available, efficient and selective differentiation protocols are needed to generate transplantable grafts. Finally, we point to the requirement of a regulatory framework necessary for the commercial use of iPS cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available